Bioinformatic analysis based on the Cancer Genome Atlas (TCGA) database initially revealed a significant association between ARL5B expression and multiple malignancies, including esophageal carcinoma (ESCA), rectum adenocarcinoma (READ), thymoma (THYM), stomach adenocarcinoma (STAD). This evidence concerns the gene ARL5B and rectum adenocarcinoma.